Maul Timothy M, Nelson Jennifer S, Wearden Peter D
Department of Cardiac Surgery, Nemours Children's Hospital, Orlando, FL, United States.
Department of Biomedical Engineering, University of Pittsburgh, Pittsburgh, PA, United States.
Front Pediatr. 2018 Sep 5;6:243. doi: 10.3389/fped.2018.00243. eCollection 2018.
Extracorporeal Membrane Oxygenation (ECMO) is a resource intensive, life-preserving support system that has seen ever-expanding clinical indications as technology and collective experience has matured. Clinicians caring for patients who develop pulmonary failure secondary to cardiac failure can find themselves in unique situations where traditional ECMO may not be the ideal clinical solution. Existing paracorporeal ventricular assist device (VAD) technology or unique patient physiologies offer the opportunity for thinking "outside the box." Hybrid ECMO approaches include splicing oxygenators into paracorporeal VAD systems and alternative cannulation strategies to provide a staged approach to transition a patient from ECMO to a VAD. Alternative technologies include the adaptation of ECMO and extracorporeal CO removal systems for specific physiologies and pediatric aged patients. This chapter will focus on: (1) hybrid and alternative approaches to extracorporeal support for pulmonary failure, (2) patient selection and, (3) technical considerations of these therapies. By examining the successes and challenges of the relatively select patients treated with these approaches, we hope to spur appropriate research and development to expand the clinical armamentarium of extracorporeal technology.
体外膜肺氧合(ECMO)是一种资源密集型的生命维持支持系统,随着技术和集体经验的成熟,其临床适应症不断扩大。照顾因心力衰竭继发肺衰竭患者的临床医生可能会发现自己处于独特的情况,传统的ECMO可能不是理想的临床解决方案。现有的体外心室辅助装置(VAD)技术或独特的患者生理状况提供了“跳出框框”思考的机会。混合ECMO方法包括将氧合器接入体外VAD系统以及采用替代插管策略,以提供一种分阶段的方法,将患者从ECMO过渡到VAD。替代技术包括针对特定生理状况和儿科患者调整ECMO和体外二氧化碳清除系统。本章将重点关注:(1)针对肺衰竭的体外支持的混合和替代方法;(2)患者选择;(3)这些治疗方法的技术考量。通过研究采用这些方法治疗的相对少数患者的成功经验和挑战,我们希望推动适当的研发工作,以扩大体外技术的临床应用范围。